Acceptance, benefits and effectiveness of the CoronaWarn-App (COVID-19 warning app)

Acceptance, benefits and effectiveness of the CoronaWarn-App (COVID-19 warning app) - Corona-Warn-App

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023685

Enrollment

500

Registered

2020-12-18

Start date

2020-12-18

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 U07 U99.0

Interventions

Group 1: Patients with evidence of infection with SARS-coV-2 to fill out a one-time questionnaire for the use of the corona warning app (COVID-19-Warn app).

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Infection with SARS-coV-2

Exclusion criteria

Exclusion criteria: lack of ability to consent

Design outcomes

Primary

Measure	Time frame
Primary endpoint is the benefit of the corona warning app regarding whether SARS-coV-2 positive patients use the app and were warned by it.	—

Secondary

Measure	Time frame
Correlation of app usage with general patient data.	—

Countries

Germany

Contacts

Public ContactAndré Jefremow

Medizinische Klinik 1 des UK Erlangen

andre.jefremow@uk-erlangen.de091318535000

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026